Home › Insider buying › SRPT

Sarepta Therapeutics, Inc. (SRPT): insider trading, Congress trades & who owns it

By CapitalSnitch Research Desk · updated Oct 11, 2026 · data from SEC filings and official Congress disclosures

Insider signal

52/100

Neutral · 90 days

Insider buys

0 buyers · 12 months

Insider sales

$417K

2 sellers · 12 months

Funds holding

323

13F · Q2 2026

Congress trades

1 member · 2 years

Insider activity at Sarepta Therapeutics, Inc. has been all selling for a year now: about $417,000 from two sellers, and zero buyers at market prices.

That's worth context: executives sell for plenty of routine reasons, from scheduled trading plans to tax bills. Buying is the rarer, more telling signal.

SRPT also shows up in congressional disclosures: 1 reported trade from one lawmaker in two years. 323 investment managers listed SRPT in their latest 13F filings (Q2 2026); more funds sold than bought. Quarter by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 0 of the last 7 full quarters.

Want the full picture on SRPT? Financials, dilution history, a written bull & bear case, top holders and alerts.

See the full SRPT report — free account

Latest insider trades in SRPT

Filed	Insider	Role	Type	Shares	Price	Value	Source
Mar 13, 2026	Mayo Stephen	Director	Sell	7,239	$17.02	$123K	SEC
Dec 18, 2025	Estepan Ian Michael	COO	Sell	13,187	$22.31	$294K	SEC
Mar 13, 2025	Nicaise Claude	Director	Sell	2,491	$99.64	$248K	SEC
Dec 16, 2024	Wigzell Hans Lennart Rudolf	Director	Sell	10,500	$124.84	$1.3M	SEC
Dec 6, 2024	Boor Kathryn Jean	Director	Sell	1,636	$125.55	$205K	SEC
Sep 3, 2024	Estepan Ian Michael	CFO	Sell	5,985	$137.36	$822K	SEC
Aug 20, 2024	Chambers Michael Andrew	Director	Buy	5,648	$134.66	$761K	SEC
Aug 20, 2024	Chambers Michael Andrew	Director	Buy	18,284	$134.06	$2.5M	SEC
Aug 20, 2024	Chambers Michael Andrew	Director	Buy	13,106	$133.07	$1.7M	SEC
Jun 25, 2024	Brown Ryan Edward	Executive Officer	Sell	3,840	$163.53	$628K	SEC
Jun 25, 2024	Brown Ryan Edward	Executive Officer	Sell	975	$160.31	$156K	SEC
Jun 25, 2024	Arif Bilal	Executive Officer	Sell	5,580	$162.31	$906K	SEC
Jun 25, 2024	Arif Bilal	Executive Officer	Sell	700	$166.10	$116K	SEC
Jun 25, 2024	Arif Bilal	Executive Officer	Sell	224	$167.13	$37K	SEC
Jun 25, 2024	Arif Bilal	Executive Officer	Sell	3,898	$163.23	$636K	SEC

Congress trades in SRPT Free

Filed	Member	Type	Amount	Source
May 6, 2025	Gilbert Ray Cisneros, Jr. D	Sale	$1,001 - $15,000	Official filing

Questions about SRPT

Are insiders buying or selling SRPT stock?

In the last 12 months Sarepta Therapeutics, Inc. insiders made open-market purchases worth about $0 and sales worth about $417,000. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.

When was the last insider trade in SRPT?

The most recent open-market insider trade in SRPT was filed on 2026-03-13.

How many institutions own SRPT?

323 investment managers reported holding SRPT in SEC Form 13F filings for Q2 2026.

Has any member of Congress traded SRPT?

Yes. Members of Congress reported 1 trades in SRPT over the past two years. The full list is free on CapitalSnitch.

Also active in insider buying

GGR BBD CRBG BPRE REF OPTU PRTA N.A.

Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.

Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).